The WellPoint Outcomes Based FormularySM: enhancing the health technology assessment process

2005 ◽  
Vol 8 (1-4) ◽  
pp. 13-25 ◽  
Author(s):  
Brian Sweet ◽  
Celynda G Tadlock ◽  
William Waugh ◽  
Andrea Hess ◽  
Ann Nguyen
Keyword(s):  
Health Technology Assessment ◽  
Technology Assessment ◽  
Health Technology ◽  
Assessment Process ◽  
Health Technology Assessment Process

scholarly journals ASSESSING THE IMPACTS OF CITIZEN DELIBERATIONS ON THE HEALTH TECHNOLOGY PROCESS – ERRATUM

2013 ◽  
Vol 29 (4) ◽  
pp. 466-466
Author(s):  
J. Abelson ◽  
Y. Bombard ◽  
F. Gauvin ◽  
D. Simeonov ◽  
S. Boesveld
Keyword(s):  
Health Technology Assessment ◽  
Technology Assessment ◽  
Health Technology ◽  
Assessment Process ◽  
Original Publication ◽  
Technology Process ◽  
Health Technology Assessment Process

In the original publication of ‘Assessing the Impacts of Citizen Deliberations on the Health Technology Process’ the title was published incorrectly. The correct title should be: Assessing the Impacts of Citizen Deliberations on the Health Technology Assessment Process. The publisher regrets this error.

OP484 Analysis Of Horizon Scanning Outputs For The National Institute for Health and Care Excellence Health Technology Assessment Process

2020 ◽  
Vol 36 (S1) ◽  
pp. 10-11
Author(s):  
Sarah Khalid Khan ◽  
Sonia Garcia Gonzalez Moral ◽  
Dapo Ogunbayo ◽  
Dawn Craig
Keyword(s):  
Health Technology Assessment ◽  
Technology Assessment ◽  
Influencing Factor ◽  
Health Technology ◽  
Assessment Process ◽  
The European Union ◽  
Time Duration ◽  
Horizon Scanning ◽  
Time Period ◽  
Health Technology Assessment Process

IntroductionThe National Institute for Health Research (NIHR) Innovation Observatory (NIHRIO) is the national Horizon Scanning (HS) organization in England, and the National Institute for Health and Care Excellence (NICE) is its key health technology assessment (HTA) stakeholder. NIHRIO has a remit to notify NICE of innovative technologies with a time horizon of three years prior to regulatory approval in the European Union (EU)/United Kingdom (UK). The notification process produces an initial ‘filtration form’ followed by a ‘technology briefing’ produced 17–20 months prior to licence for those technologies that NICE will consider for appraisal. Since April 2017, NIHRIO has produced ~400 technology briefings. We present an analysis of how this has fed into the NICE HTA process so far.MethodsThe analysis mapped NIHRIO's technology briefings (April 2017 – June 2020) with relevant NICE technology appraisal/highly specialized technologies (TA/HST) guidance during the time period. The analysis followed the timeline of technologies from identification during the horizon scanning process to filtration to briefing submission to NICE and entering the TA/HST process to outcome/recommendation given by NICE.ResultsUntil June 2020, 496 technology briefings entered the NICE TA/HST scoping process. Forty per cent are in progress, four per cent have had a TA/HST recommendation and three per cent that entered the NICE TA/HST scoping process did not complete it. On average it took less time from briefing submission to NICE recommendation for cancer indications. The time from discovery to NICE recommendation ranged from 115 months to 22 months.ConclusionsHS for TA/HST is a lengthy process from identification to final recommendation and there is considerable variation in time duration from identification to briefing submission to NICE recommendation. Average time taken from briefing submission to NICE recommendation is shorter for cancer indications and repurposed medicines. A full TA/HST may not be recommended for all technology briefings, rather they may update existing guidance or find different routes of evaluation. Technologies that enter the TA/HST scoping process might be terminated, suspended or discontinued for several reasons which may include lack of company engagement, change in development or regulatory plans by the company. Timely notification is key in achieving TA/HST recommendation at the time of market authorization but not the only influencing factor.

Health technology assessment process of a cardiovascular medical device in four different settings

2017 ◽  
Vol 6 (7) ◽  
pp. 591-600
Author(s):  
Antonio Olry de Labry Lima ◽  
Jaime Espín Balbino ◽  
Alexandre Lemgruber ◽  
Araceli Caro Martínez ◽  
Leticia García-Mochón ◽  
...  
Keyword(s):  
Health Technology Assessment ◽  
Medical Device ◽  
Technology Assessment ◽  
Health Technology ◽  
Assessment Process ◽  
Health Technology Assessment Process

The Iterative Use of Economic Evaluation as Part of the Process of Health Technology Assessment

1997 ◽  
Vol 2 (1) ◽  
pp. 26-30 ◽  
Author(s):  
Mark Sculpher ◽  
Michael Drummond ◽  
Martin Buxton
Keyword(s):  
Health Care ◽  
Clinical Practice ◽  
Economic Evaluation ◽  
Health Technology Assessment ◽  
Technology Assessment ◽  
Stage Iv ◽  
Health Technology ◽  
Routine Clinical Practice ◽  
Assessment Process ◽  
Health Technology Assessment Process

The Economic evaluation of health care technologies has a key role within the new National Health Service health technology assessment process. There has, however, been little discussion of the best way of combining economic and clinical research. Economic evaluation should be iterative, generating progressively firmer estimates of cost-effectiveness and helping to maximise the efficiency of health care R&D. Here, four stages of economic analysis are suggested, starting with stage I when the basic clinical science is complete, and finishing with stage IV analysis to generalise the results of earlier studies to routine clinical practice.

Sign in / Sign up

Export Citation Format

Share Document